First Time Loading...

4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.6 AUD -1.64% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

4DX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. [ Read More ]

The intrinsic value of one 4DX stock under the Base Case scenario is 0.48 AUD. Compared to the current market price of 0.6 AUD, 4DMedical Ltd is Overvalued by 20%.

Key Points:
4DX Intrinsic Value
Base Case
0.48 AUD
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
4DMedical Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling 4DX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
4DMedical Ltd

Provide an overview of the primary business activities
of 4DMedical Ltd.

What unique competitive advantages
does 4DMedical Ltd hold over its rivals?

What risks and challenges
does 4DMedical Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for 4DMedical Ltd.

Provide P/S
for 4DMedical Ltd.

Provide P/E
for 4DMedical Ltd.

Provide P/OCF
for 4DMedical Ltd.

Provide P/FCFE
for 4DMedical Ltd.

Provide P/B
for 4DMedical Ltd.

Provide EV/S
for 4DMedical Ltd.

Provide EV/GP
for 4DMedical Ltd.

Provide EV/EBITDA
for 4DMedical Ltd.

Provide EV/EBIT
for 4DMedical Ltd.

Provide EV/OCF
for 4DMedical Ltd.

Provide EV/FCFF
for 4DMedical Ltd.

Provide EV/IC
for 4DMedical Ltd.

Show me price targets
for 4DMedical Ltd made by professional analysts.

What are the Revenue projections
for 4DMedical Ltd?

How accurate were the past Revenue estimates
for 4DMedical Ltd?

What are the Net Income projections
for 4DMedical Ltd?

How accurate were the past Net Income estimates
for 4DMedical Ltd?

What are the EPS projections
for 4DMedical Ltd?

How accurate were the past EPS estimates
for 4DMedical Ltd?

What are the EBIT projections
for 4DMedical Ltd?

How accurate were the past EBIT estimates
for 4DMedical Ltd?

Compare the revenue forecasts
for 4DMedical Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of 4DMedical Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of 4DMedical Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of 4DMedical Ltd compared to its peers.

Compare the P/E ratios
of 4DMedical Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing 4DMedical Ltd with its peers.

Analyze the financial leverage
of 4DMedical Ltd compared to its main competitors.

Show all profitability ratios
for 4DMedical Ltd.

Provide ROE
for 4DMedical Ltd.

Provide ROA
for 4DMedical Ltd.

Provide ROIC
for 4DMedical Ltd.

Provide ROCE
for 4DMedical Ltd.

Provide Gross Margin
for 4DMedical Ltd.

Provide Operating Margin
for 4DMedical Ltd.

Provide Net Margin
for 4DMedical Ltd.

Provide FCF Margin
for 4DMedical Ltd.

Show all solvency ratios
for 4DMedical Ltd.

Provide D/E Ratio
for 4DMedical Ltd.

Provide D/A Ratio
for 4DMedical Ltd.

Provide Interest Coverage Ratio
for 4DMedical Ltd.

Provide Altman Z-Score Ratio
for 4DMedical Ltd.

Provide Quick Ratio
for 4DMedical Ltd.

Provide Current Ratio
for 4DMedical Ltd.

Provide Cash Ratio
for 4DMedical Ltd.

What is the historical Revenue growth
over the last 5 years for 4DMedical Ltd?

What is the historical Net Income growth
over the last 5 years for 4DMedical Ltd?

What is the current Free Cash Flow
of 4DMedical Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for 4DMedical Ltd.

Financials

Balance Sheet Decomposition
4DMedical Ltd

Current Assets 61.7m
Cash & Short-Term Investments 47.9m
Receivables 10.3m
Other Current Assets 3.4m
Non-Current Assets 82.1m
PP&E 8.4m
Intangibles 73.6m
Other Non-Current Assets 44.8k
Current Liabilities 33.9m
Accounts Payable 7.3m
Accrued Liabilities 1.5m
Other Current Liabilities 25.1m
Non-Current Liabilities 18.7m
Long-Term Debt 3.9m
Other Non-Current Liabilities 14.8m
Efficiency

Earnings Waterfall
4DMedical Ltd

Revenue
1m AUD
Cost of Revenue
-51.3k AUD
Gross Profit
973.9k AUD
Operating Expenses
-32.6m AUD
Operating Income
-31.6m AUD
Other Expenses
803.3k AUD
Net Income
-30.8m AUD

Free Cash Flow Analysis
4DMedical Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

4DX Profitability Score
Profitability Due Diligence

4DMedical Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive Gross Profit
ROE is Increasing
34/100
Profitability
Score

4DMedical Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

4DX Solvency Score
Solvency Due Diligence

4DMedical Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
75/100
Solvency
Score

4DMedical Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

4DX Price Targets Summary
4DMedical Ltd

Wall Street analysts forecast 4DX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4DX is 1.16 AUD with a low forecast of 1.11 AUD and a high forecast of 1.26 AUD.

Lowest
Price Target
1.11 AUD
85% Upside
Average
Price Target
1.16 AUD
93% Upside
Highest
Price Target
1.26 AUD
110% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

4DX Price
4DMedical Ltd

1M 1M
-5%
6M 6M
+25%
1Y 1Y
-33%
3Y 3Y
-62%
5Y 5Y
-62%
10Y 10Y
-62%
Annual Price Range
0.6
52w Low
0.45
52w High
1.16
Price Metrics
Average Annual Return -20.87%
Standard Deviation of Annual Returns 65.47%
Max Drawdown -89%
Shares Statistics
Market Capitalization 234.5m AUD
Shares Outstanding 391 375 000
Percentage of Shares Shorted
N/A

4DX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

4DMedical Ltd Logo
4DMedical Ltd

Country

Australia

Industry

Health Care

Market Cap

234.5m AUD

Dividend Yield

0%

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

Contact

VICTORIA
Melbourne
5/468 St. Kilda Road
+61395455940.0
https://4dmedical.com/

IPO

2020-08-07

Employees

-

Officers

Founder, MD, CEO & Director
Dr. Andreas Fouras M.A.I.C.D., Ph.D.
Chief Financial Officer
Mr. Simon Glover
Executive Director
Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc
Company Secretary & General Counsel
Ms. Naomi Lawrie
Chief of Staff
Ms. Rachael Tenkaten
Senior Vice President of Engineering
Dr. Aidan Jamison B.E., Ph.D.
Show More
Chief Software Architect
Dr. Michael Curtis Ph.D.
Chief Research Officer
Dr. Jon Dusting Ph.D.
Senior Vice President of Medical & Clinical Affairs
Dr. Jason Kirkness Ph.D.
Chief Commercial Officer
Mr. Matt Tucker
Show Less

See Also

Discover More
What is the Intrinsic Value of one 4DX stock?

The intrinsic value of one 4DX stock under the Base Case scenario is 0.48 AUD.

Is 4DX stock undervalued or overvalued?

Compared to the current market price of 0.6 AUD, 4DMedical Ltd is Overvalued by 20%.